Clinical Trial Update: Dexmedetomidine and Esmolol Early Post Operative Cognitive Dysfunction [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update investigating dexmedetomidine and esmolol for early postoperative cognitive dysfunction in a Phase 1/2 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Dysfunction

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Esmolol (esmolol)

Snippet

Sponsor: Beni-Suef University | Conditions: Cognitive Dysfunction | Phase 1, Phase 2 | Status: UNKNOWN